DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 94 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q3 2022. The put-call ratio across all filers is 0.34 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,094,510 | +38.3% | 89,203 | +34.6% | 0.00% | 0.0% |
| Q2 2023 | $791,156 | +134450.3% | 66,261 | +50.6% | 0.00% | 0.0% |
| Q1 2023 | $588 | -36.4% | 43,996 | +2.4% | 0.00% | 0.0% |
| Q4 2022 | $924 | -99.9% | 42,953 | +1.7% | 0.00% | 0.0% |
| Q3 2022 | $846,000 | +39.1% | 42,242 | +24.4% | 0.00% | 0.0% |
| Q2 2022 | $608,000 | +215.0% | 33,954 | +74.9% | 0.00% | – |
| Q1 2022 | $193,000 | – | 19,408 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 6,964,301 | $139,495,000 | 56.26% |
| PATHWAY CAPITAL MANAGEMENT, LP | 403,127 | $8,075,000 | 25.88% |
| Atlas Venture Life Science Advisors, LLC | 8,169,171 | $163,628,000 | 18.06% |
| RA Capital Management | 7,040,622 | $141,024,000 | 3.01% |
| COMMODORE CAPITAL LP | 739,661 | $14,815,000 | 2.38% |
| Nicholas Investment Partners, LP | 757,407 | $15,171,000 | 1.41% |
| Boxer Capital, LLC | 1,189,943 | $23,835,000 | 1.34% |
| Parkman Healthcare Partners LLC | 212,191 | $4,250,000 | 1.21% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $8,012,000 | 0.98% |
| Samsara BioCapital, LLC | 196,425 | $3,934,000 | 0.92% |